Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fruit salt fights indigestion in minutes – new study

NCT ID NCT07140341

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed Phase 3 trial tested whether ENO Lime, a fruit salt powder, can quickly ease symptoms of indigestion, acidity, and nausea. Forty adults with recent symptoms took a single dose, and their discomfort was measured before and 15 minutes after. The study aimed to see if this over-the-counter remedy provides fast symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ENO Lime (fruit salt powder containing Svarjiksara and lime flavor)
What this could lead to
If it works, this could confirm that ENO Lime provides fast relief from indigestion and acidity symptoms.
What could go wrong
This is a small, single-arm study with no placebo group, so results may not prove effectiveness. The 15-minute follow-up is very short, and long-term benefits are not assessed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

40 people

The number who actually took part.

Started

Aug 2025

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and female participants with age 18-60 years (both inclusive). * Participants newly experiencing symptom/s of Ajeerna vyadhi for not more than 10 days. * Participants with at least one symptom of Ajeerna vyadhi (according to Charak Samhita and Madhav Nidan) that is acidity (heartburn), acid indigestion (epigastric pain), indigestion (abdominal discomfort), or associated nausea. * Participants with VAS score greater than or equal to (\>=) 40-mm and less than or equal to (\<=) 80-mm Ajeerna vyadhi (acidity, acid indigestion, indigestion, or associated nausea) at the Baseline visit. * Participants are able to read, understand, and provide written informed consent. * Participants who can understand and complete the VAS. Exclusion Criteria: * Participants with chronic and recurrent cases of Ajeerna vyadhi. * Participants with Updrava of Ajeerna vyadhi (Complications of indigestion). * Pregnant women (self-reported) and breastfeeding females or females intending to become pregnant during the study. * Participant had surgery in the last 14 days. * Participant has been exposed to barium meal 3 days before screening. * Participants already on any indigestion or acidity medication. * Participants taking any medicinal/over-the-counter (OTC)/ herbal medicine from the past 3 days. * Participants on medications that could interact with ENO Lime (example, antacids, proton pump inhibitors, or H2 blockers) as per the judgment of the Investigator/designee. * Participants with known hypersensitivity to any of the components of ENO Lime (Svarjiksara \[Shudh\], Nimbu Rasa \[Citrus limon, Fruit Juice Powder\]). * Participants with a history of gastrointestinal (GI) disorders such as peptic ulcers, gastritis, irritable bowel syndrome (IBS), or other serious GI diseases. * Participants with serious renal, hepatic, or cardiovascular diseases. * Participants on a sodium restricted diet example, those suffering from hypertension or congestive heart failure. * Participants who have participated in another clinical trial within the last 30 days. * Any participant who, in the opinion of the investigator, should not participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Indigestion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lifepoint Hospital

    Pune, Maharashtra, 411057, India

  • Ojas Hospital

    Pune, Maharashtra, 412101, India

  • Shri Krishna Super Speciality Institute of Ayurveda

    New Delhi, 110058, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.